{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:39:17Z","timestamp":1761100757341},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2005,4,18]],"date-time":"2005-04-18T00:00:00Z","timestamp":1113782400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2005,4,18]],"date-time":"2005-04-18T00:00:00Z","timestamp":1113782400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2005,6,1]]},"DOI":"10.1038\/sj.bmt.1704974","type":"journal-article","created":{"date-parts":[[2005,4,18]],"date-time":"2005-04-18T09:14:12Z","timestamp":1113815652000},"page":"1141-1148","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Autologous and allogeneic stem cell transplantation in adult ALL: the Swedish Adult ALL Group experience"],"prefix":"10.1038","volume":"35","author":[{"given":"H","family":"Hallb\u00f6\u00f6k","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"H\u00e4gglund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Stockelberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P-G","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Karlsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Bj\u00f6rkholm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Linderholm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Wahlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O","family":"Linder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B","family":"Smedmyr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"for the Swedish Adult ALL Group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2005,4,18]]},"reference":[{"key":"BF1704974_CR1","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1002\/cncr.11664","volume":"98","author":"S Faderl","year":"2003","unstructured":"Faderl S, Jeha S, Kantarjian HM . The biology and therapy of adult acute lymphoblastic leukemia. Cancer 2003; 98: 1337\u20131354.","journal-title":"Cancer"},{"key":"BF1704974_CR2","doi-asserted-by":"publisher","first-page":"856a","DOI":"10.1182\/blood.V98.5.1302","volume":"98","author":"AP Goldstone","year":"2001","unstructured":"Goldstone AP, Prentice HG, Durrant J et al. Allogeneic transplant (related or unrelated donor) is the preferred treatment for adult Philadelphia chromosome positive (Ph+) acute lymphoblastic leukemia (ALL). Results from the International ALL Trial (MRC UKALLXII\/ECOG E2993). Blood 2001; 98: 856a (abstract).","journal-title":"Blood"},{"key":"BF1704974_CR3","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/sj.bmt.1704368","volume":"33","author":"V Gupta","year":"2004","unstructured":"Gupta V, Yi QL, Brandwein J et al. The role of allogeneic bone marrow transplantation in adult patients below the age of 55 years with acute lymphoblastic leukemia in first complete remission: a donor vs no donor comparison. Bone Marrow Transplant 2004; 33: 397\u2013404.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704974_CR4","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1182\/blood-2002-03-0704","volume":"100","author":"H Dombret","year":"2002","unstructured":"Dombret H, Gabert J, Boiron JM et al. Outcome of treatment in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia \u2013 results of the prospective multicenter LALA-94 trial. Blood 2002; 100: 2357\u20132366.","journal-title":"Blood"},{"key":"BF1704974_CR5","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.bbmt.2003.11.002","volume":"10","author":"A Nordlander","year":"2004","unstructured":"Nordlander A, Mattsson J, Ringden O et al. Graft-versus-host disease is associated with a lower relapse incidence after hematopoietic stem cell transplantation in patients with acute lymphoblastic leukemia. Biol Blood Marrow Transplant 2004; 10: 195\u2013203.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BF1704974_CR6","first-page":"896","volume":"83","author":"P Zikos","year":"1998","unstructured":"Zikos P, Van Lint MT, Lamparelli T et al. Allogeneic hemopoietic stem cell transplantation for patients with high risk acute lymphoblastic leukemia: favorable impact of chronic graft-versus-host disease on survival and relapse. Haematologica 1998; 83: 896\u2013903.","journal-title":"Haematologica"},{"key":"BF1704974_CR7","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/sj.bmt.1701064","volume":"21","author":"JR Passweg","year":"1998","unstructured":"Passweg JR, Tiberghien P, Cahn JY et al. Graft-versus-leukemia effects in T lineage and B lineage acute lymphoblastic leukemia. Bone Marrow Transplant 1998; 21: 153\u2013158.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704974_CR8","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1200\/JCO.1983.1.8.462","volume":"1","author":"P Schauer","year":"1983","unstructured":"Schauer P, Arlin ZA, Mertelsmann R et al. Treatment of acute lymphoblastic leukemia in adults: results of the L-10 and L-10\u2009M protocols. J Clin Oncol 1983; 1: 462\u2013470.","journal-title":"J Clin Oncol"},{"key":"BF1704974_CR9","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1046\/j.1365-2141.2002.03685.x","volume":"118","author":"H Hallbook","year":"2002","unstructured":"Hallbook H, Simonsson B, Ahlgren T et al. High-dose cytarabine in upfront therapy for adult patients with acute lymphoblastic leukaemia. Br J Haematol 2002; 118: 748\u2013754.","journal-title":"Br J Haematol"},{"key":"BF1704974_CR10","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1182\/blood.V87.2.495.bloodjournal872495","volume":"87","author":"D Hoelzer","year":"1996","unstructured":"Hoelzer D, Ludwig WD, Thiel E et al. Improved outcome in adult B-cell acute lymphoblastic leukemia. Blood 1996; 87: 495\u2013508.","journal-title":"Blood"},{"key":"BF1704974_CR11","first-page":"3294","volume":"94","author":"A Reiter","year":"1999","unstructured":"Reiter A, Schrappe M, Tiemann M et al. Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: a report of the Berlin\u2013Frankfurt\u2013Munster Group Trial NHL-BFM 90. Blood 1999; 94: 3294\u20133306.","journal-title":"Blood"},{"key":"BF1704974_CR12","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/0002-9343(80)90380-0","volume":"69","author":"HM Shulman","year":"1980","unstructured":"Shulman HM, Sullivan KM, Weiden PL et al. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med 1980; 69: 204\u2013217.","journal-title":"Am J Med"},{"key":"BF1704974_CR13","first-page":"825","volume":"15","author":"D Przepiorka","year":"1995","unstructured":"Przepiorka D, Weisdorf D, Martin P et al. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant 1995; 15: 825\u2013828.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704974_CR14","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/S1083-8791(03)00149-6","volume":"9","author":"K Doney","year":"2003","unstructured":"Doney K, Hagglund H, Leisenring W et al. Predictive factors for outcome of allogeneic hematopoietic cell transplantation for adult acute lymphoblastic leukemia. Biol Blood Marrow Transplant 2003; 9: 472\u2013481.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BF1704974_CR15","doi-asserted-by":"publisher","first-page":"4655","DOI":"10.1200\/JCO.2002.12.049","volume":"20","author":"O Ringden","year":"2002","unstructured":"Ringden O, Labopin M, Bacigalupo A et al. Transplantation of peripheral blood stem cells as compared with bone marrow from HLA-identical siblings in adult patients with acute myeloid leukemia and acute lymphoblastic leukemia. J Clin Oncol 2002; 20: 4655\u20134664.","journal-title":"J Clin Oncol"},{"key":"BF1704974_CR16","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/S0301-472X(03)00231-5","volume":"31","author":"CH Jamieson","year":"2003","unstructured":"Jamieson CH, Amylon MD, Wong RM, Blume KG . Allogeneic hematopoietic cell transplantation for patients with high-risk acute lymphoblastic leukemia in first or second complete remission using fractionated total-body irradiation and high-dose etoposide: a 15-year experience. Exp Hematol 2003; 31: 981\u2013986.","journal-title":"Exp Hematol"},{"key":"BF1704974_CR17","doi-asserted-by":"crossref","first-page":"5251","DOI":"10.1182\/blood.V87.12.5251.bloodjournal87125251","volume":"87","author":"J Brisco","year":"1996","unstructured":"Brisco J, Hughes E, Neoh SH et al. Relationship between minimal residual disease and outcome in adult acute lymphoblastic leukemia. Blood 1996; 87: 5251\u20135256.","journal-title":"Blood"},{"key":"BF1704974_CR18","doi-asserted-by":"publisher","first-page":"3774","DOI":"10.1200\/JCO.1998.16.12.3774","volume":"16","author":"J Ciudad","year":"1998","unstructured":"Ciudad J, San Miguel JF, Lopez-Berges MC et al. Prognostic value of immunophenotypic detection of minimal residual disease in acute lymphoblastic leukemia. J Clin Oncol 1998; 16: 3774\u20133781.","journal-title":"J Clin Oncol"},{"key":"BF1704974_CR19","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1053\/beha.2002.0186","volume":"15","author":"L Foroni","year":"2002","unstructured":"Foroni L, Hoffbrand AV . Molecular analysis of minimal residual disease in adult acute lymphoblastic leukaemia. Best Pract Res Clin Haematol 2002; 15: 71\u201390.","journal-title":"Best Pract Res Clin Haematol"},{"key":"BF1704974_CR20","doi-asserted-by":"publisher","first-page":"4695","DOI":"10.1182\/blood-2002-08-2613","volume":"101","author":"MB Vidriales","year":"2003","unstructured":"Vidriales MB, Perez JJ, Lopez-Berges C et al. Minimal residual disease (MRD) in adolescent (>14 years) and adult acute lymphoblastic leukaemias (ALL): early immunophenotypical evaluation has high clinical value. Blood 2003; 101: 4695\u20134700.","journal-title":"Blood"},{"key":"BF1704974_CR21","doi-asserted-by":"publisher","first-page":"2580","DOI":"10.1200\/JCO.1994.12.12.2580","volume":"12","author":"C Sebban","year":"1994","unstructured":"Sebban C, Lepage E, Vernant JP et al. Allogeneic bone marrow transplantation in adult acute lymphoblastic leukemia in first complete remission: a comparative study. French Group of Therapy of Adult Acute Lymphoblastic Leukemia. J Clin Oncol 1994; 12: 2580\u20132587.","journal-title":"J Clin Oncol"},{"key":"BF1704974_CR22","doi-asserted-by":"publisher","first-page":"4075","DOI":"10.1200\/JCO.2004.10.050","volume":"22","author":"X Thomas","year":"2004","unstructured":"Thomas X, Boiron JM, Huguet F et al. Outcome of treatment in adults with acute lymphoblastic leukemia: analysis of the LALA-94 trial. J Clin Oncol 2004; 22: 4075\u20134086.","journal-title":"J Clin Oncol"},{"key":"BF1704974_CR23","doi-asserted-by":"publisher","first-page":"13","DOI":"10.7326\/0003-4819-115-1-13","volume":"115","author":"MM Horowitz","year":"1991","unstructured":"Horowitz MM, Messerer D, Hoelzer D et al. Chemotherapy compared with bone marrow transplantation for adults with acute lymphoblastic leukemia in first remission. Ann Intern Med 1991; 115: 13\u201318.","journal-title":"Ann Intern Med"},{"key":"BF1704974_CR24","doi-asserted-by":"publisher","first-page":"428","DOI":"10.7326\/0003-4819-123-6-199509150-00006","volume":"123","author":"MJ Zhang","year":"1995","unstructured":"Zhang MJ, Hoelzer D, Horowitz MM et al. Long-term follow-up of adults with acute lymphoblastic leukemia in first remission treated with chemotherapy or bone marrow transplantation. The Acute Lymphoblastic Leukemia Working Committee. Ann Intern Med 1995; 123: 428\u2013431.","journal-title":"Ann Intern Med"},{"key":"BF1704974_CR25","first-page":"1619","volume":"86","author":"M Attal","year":"1995","unstructured":"Attal M, Blaise D, Marit G et al. Consolidation treatment of adult acute lymphoblastic leukemia: a prospective, randomized trial comparing allogeneic versus autologous bone marrow transplantation and testing the impact of recombinant interleukin-2 after autologous bone marrow transplantation. BGMT Group. Blood 1995; 86: 1619\u20131628.","journal-title":"BGMT Group. Blood"},{"key":"BF1704974_CR26","first-page":"481a","volume":"98","author":"JR Rowe","year":"2001","unstructured":"Rowe JR, Richards SM, Burnett AK et al. Favorable results of allogeneic bone marrow transplantation for adults with Philadelphia-chromosome-negative acute lymphoblastic leukemia in first complete remission: results from the International ALL Trial (MRC UKALL XII\/ECOG E2993). Blood 2001; 98: 481a (abstract).","journal-title":"Blood"},{"key":"BF1704974_CR27","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1053\/bbmt.2002.v8.pm12014810","volume":"8","author":"D Weisdorf","year":"2002","unstructured":"Weisdorf D, Bishop M, Dharan B et al. Autologous versus allogeneic unrelated donor transplantation for acute lymphoblastic leukemia: comparative toxicity and outcomes. Biol Blood Marrow Transplant 2002; 8: 213\u2013220.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BF1704974_CR28","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1182\/blood-2001-12-0181","volume":"100","author":"OG Ottmann","year":"2002","unstructured":"Ottmann OG, Druker BJ, Sawyers CL et al. A phase 2 study of imatinib in patients with relapsed or refractory Philadelphia chromosome-positive acute lymphoid leukemias. Blood 2002; 100: 1965\u20131971.","journal-title":"Blood"},{"key":"BF1704974_CR29","doi-asserted-by":"publisher","first-page":"4396","DOI":"10.1182\/blood-2003-08-2958","volume":"103","author":"DA Thomas","year":"2004","unstructured":"Thomas DA, Faderl S, Cortes J et al. Treatment of Philadelphia chromosome-positive acute lymphocytic leukemia with hyper-CVAD and imatinib mesylate. Blood 2004; 103: 4396\u20134407.","journal-title":"Blood"},{"key":"BF1704974_CR30","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1182\/blood.V97.6.1572","volume":"97","author":"JJ Cornelissen","year":"2001","unstructured":"Cornelissen JJ, Carston M, Kollman C et al. Unrelated marrow transplantation for adult patients with poor-risk acute lymphoblastic leukemia: strong graft-versus-leukemia effect and risk factors determining outcome. Blood 2001; 97: 1572\u20131577.","journal-title":"Blood"},{"key":"BF1704974_CR31","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1038\/sj.leu.2403030","volume":"17","author":"NC Gorin","year":"2003","unstructured":"Gorin NC, Labopin M, Polge E et al. Risk assessment in adult acute lymphoblastic leukaemia before early haemopoietic stem cell transplantation with a geno-identical donor: an easy clinical prognostic score to identify patients who benefit most from allogeneic haemopoietic stem cell transplantation. Leukemia 2003; 17: 1596\u20131599.","journal-title":"Leukemia"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1704974","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1704974.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1704974.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,24]],"date-time":"2022-03-24T00:34:54Z","timestamp":1648082094000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1704974"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4,18]]},"references-count":31,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2005,6,1]]}},"alternative-id":["BF1704974"],"URL":"https:\/\/doi.org\/10.1038\/sj.bmt.1704974","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"type":"print","value":"0268-3369"},{"type":"electronic","value":"1476-5365"}],"subject":[],"published":{"date-parts":[[2005,4,18]]},"assertion":[{"value":"18 November 2004","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2005","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2005","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}